Creative Medical Technology Holdings, Inc.
CELZ
$2.13
-$0.0108-0.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -78.26% | 33.23% | -49.56% | 37.95% | -15.45% |
| Total Depreciation and Amortization | -22.87% | 0.00% | 0.00% | 14.90% | 10.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 0.00% | 0.00% | 136.95% | -370.65% |
| Change in Net Operating Assets | -890.68% | -67.80% | -52.92% | 148.94% | -285.15% |
| Cash from Operations | -97.80% | 32.92% | -63.82% | 52.67% | -45.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -100.00% | 598.17% | -53.63% |
| Cash from Investing | 100.00% | -- | -100.00% | 598.17% | -53.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 61.77% | 19.44% | -4.55% | 58.71% |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,490.20% | 61.71% | 19.57% | -4.55% | 58.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.58% | 21.15% | -127.72% | 632.64% | -300.97% |